loadpatents
Patent applications and USPTO patent grants for Heer; Jag Paul.The latest application filed is for "functionalised amine derivatives as il-17 modulators".
Patent | Date |
---|---|
Functionalised Amine Derivatives as IL-17 Modulators App 20220073485 - Foley; Anne Marie ;   et al. | 2022-03-10 |
Fused Pentacyclic Imidazole Derivatives App 20210155637 - De Haro Garcia; Teresa ;   et al. | 2021-05-27 |
Fused pentacyclic imidazole derivatives as modulators of TNF activity Grant 10,953,019 - Brown , et al. March 23, 2 | 2021-03-23 |
Fused pentacyclic imidazole derivatives Grant 10,906,919 - De Haro Garcia , et al. February 2, 2 | 2021-02-02 |
Pharmaceutical 6,5 Heterobicyclic Ring Derivatives App 20200399268 - Heer; Jag Paul ;   et al. | 2020-12-24 |
Fused pentacyclic imidazole derivatives as modulators of TNF activity Grant 10,793,578 - Heer , et al. October 6, 2 | 2020-10-06 |
Fused hexacyclic imidazole derivatives as modulators of TNF activity Grant 10,766,906 - De Haro Garcia , et al. Sep | 2020-09-08 |
Substituted benzimidazole derivative as a modulator of TNF activity Grant 10,669,263 - Heer | 2020-06-02 |
Fused pentacyclic imidazole derivatives as modulators of TNF activity Grant 10,669,286 - Deligny , et al. | 2020-06-02 |
Fused pentacyclic imidazole derivatives as modulators of TNF activity Grant 10,654,861 - Deligny , et al. | 2020-05-19 |
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity App 20200022988 - Brown; Julien Alistair ;   et al. | 2020-01-23 |
Fused Pentacyclic Imidazole Derivatives App 20190367535 - De Haro Garcia; Teresa ;   et al. | 2019-12-05 |
Fused tricyclic imidazo pyrazines as modulators of TNF activity Grant 10,472,362 - Jackson , et al. Nov | 2019-11-12 |
Substituted Benzimidazole Derivative as a Modulator of TNF Activity App 20190284170 - Heer; Jag Paul | 2019-09-19 |
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity App 20190119302 - Deligny; Michael Louis Robert ;   et al. | 2019-04-25 |
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity App 20190112314 - Heer; Jag Paul ;   et al. | 2019-04-18 |
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity App 20190100525 - Deligny; Michael Louis Robert ;   et al. | 2019-04-04 |
Fused Hexacyclic Imidazole Derivatives as Modulators of TNF Activity App 20190100526 - De Haro Garcia; Teresa ;   et al. | 2019-04-04 |
Fused pentacyclic imidazole derivatives Grant 10,202,405 - De Haro Garcia , et al. Feb | 2019-02-12 |
Fused Tricyclic Imidazo Pyrazines as Modulators of TNF Activity App 20180298006 - JACKSON; Victoria Elizabeth ;   et al. | 2018-10-18 |
Tetrahydrobenzimidazole derivatives as modulators of TNF activity Grant 10,093,652 - Heer , et al. October 9, 2 | 2018-10-09 |
Fused tricyclic imidazole derivatives as modulators of TNF activity Grant 10,087,179 - Alexander , et al. October 2, 2 | 2018-10-02 |
Tetrahydroimidazopyridine derivatives as modulators of TNF activity Grant 9,969,728 - Defays , et al. May 15, 2 | 2018-05-15 |
Fused tricyclic benzimidazoles derivatives as modulators of TNF activity Grant 9,932,343 - Alexander , et al. April 3, 2 | 2018-04-03 |
Imidazopyridine derivatives as modulators of TNF activity Grant 9,926,313 - Deligny , et al. March 27, 2 | 2018-03-27 |
Fused Tricyclic imidazole derivatives as modulators of TNF activity Grant 9,890,174 - Alexander , et al. February 13, 2 | 2018-02-13 |
Fused Pentacyclic Imidazole Derivatives App 20170305932 - De Haro Garcia; Teresa ;   et al. | 2017-10-26 |
Fused Tricyclic Imidazole Derivatives As Modulators of TNF Activity App 20160376268 - ALEXANDER; Rikki Peter ;   et al. | 2016-12-29 |
Fused Tricyclic Benzimidazoles Derivatives As Modulators of TNF Activity App 20160304523 - Alexander; Rikki Peter ;   et al. | 2016-10-20 |
Imidazopyridine Derivatives As Modulators of TNF Activity App 20160304513 - Deligny; Michael Louis Robert ;   et al. | 2016-10-20 |
Fused Tricyclic Imidazole Derivatives As Modulators of TNF Activity App 20160304530 - Alexander; Rikki Peter ;   et al. | 2016-10-20 |
Tetrahydrobenzimidazole Derivatives as Modulators of TNF Activity App 20160297795 - Heer; Jag Paul ;   et al. | 2016-10-13 |
Tetrahydroimidazopyridine Derivatives as Modulators of TNF Activity App 20160289228 - Defays; Sabine ;   et al. | 2016-10-06 |
Piperazine derivatives for blocking Ca.sub.v2.2 calcium channels Grant 8,697,703 - Heer , et al. April 15, 2 | 2014-04-15 |
3-pyridylcarbonyl-piperazinylsulfonyl derivatives Grant 8,536,183 - Beswick , et al. September 17, 2 | 2013-09-17 |
Piperazine derivatives used as CAV2.2 calcium channel modulators Grant 8,530,478 - Beswick , et al. September 10, 2 | 2013-09-10 |
PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS App 20130072499 - Heer; Jag Paul ;   et al. | 2013-03-21 |
Compounds Grant 8,329,730 - Heightman , et al. December 11, 2 | 2012-12-11 |
3-pyridylcarbonyl-piperazinylsulfonyl Derivatives App 20120302746 - Beswick; Paul John ;   et al. | 2012-11-29 |
3-pyridylcarbonyl-piperazinylsulfonyl derivatives Grant 8,288,388 - Beswick , et al. October 16, 2 | 2012-10-16 |
Oxadiazole derivatives active on sphingosine-1-phosphate (S1P) Grant 8,278,324 - Heer , et al. October 2, 2 | 2012-10-02 |
Oxadiazole derivatives active on sphingosine-1-phosphate (SIP) Grant 8,263,620 - Heer , et al. September 11, 2 | 2012-09-11 |
Oxadiazole derivatives active on sphingosine-1-phosphate (S1P) Grant 8,222,245 - Demont , et al. July 17, 2 | 2012-07-17 |
Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives Grant 8,093,249 - Heer , et al. January 10, 2 | 2012-01-10 |
Piperazine Derivatives Used As Cav2.2 Calcium Channel Modulators App 20110130379 - Beswick; Paul John ;   et al. | 2011-06-02 |
Compounds App 20110039889 - Eldred; Colin David ;   et al. | 2011-02-17 |
Oxadiazole Derivatives Active On Sphingosine-1-phosphate (sip) App 20100298373 - Heer; Jag Paul ;   et al. | 2010-11-25 |
1, 2, 4 -oxadiazole Compounds For The Treatment Of Autoimmune Diseases App 20100273770 - Heer; Jag Paul ;   et al. | 2010-10-28 |
Oxadiazole Derivatives Active On Sphingosine-1-phosphate (sip) App 20100273771 - Demont; Emmanuel Hubert ;   et al. | 2010-10-28 |
OXADIAZOLE DERIVATIVES ACTIVE ON SPHINGOSINE-1-PHOSPHATE (S1p) App 20100273827 - Heer; Jag Paul | 2010-10-28 |
Oxadiazole Derivatives For Use As S1p1 Agonists In The Treatment Of Autoimmune And Inflammatory Disorders App 20100261767 - Heer; Jag Paul ;   et al. | 2010-10-14 |
Novel Compounds App 20100227870 - Gianotti; Massimo ;   et al. | 2010-09-09 |
Xanthine Derivatives As Selective Hm74a Agonists App 20100179128 - Hatley; Richard Jonathan Daniel ;   et al. | 2010-07-15 |
Compounds App 20100174065 - HEER; Jag Paul ;   et al. | 2010-07-08 |
Oxadiazole Derivatives Active On Sphingosine-1-phosphate (s1p) App 20100152235 - Heer; Jag Paul ;   et al. | 2010-06-17 |
Xanthine Derivatives As Selective Hm74a Agonists App 20100099690 - Heer; Jag Paul ;   et al. | 2010-04-22 |
Novel Derivatives App 20100022555 - Beswick; Paul John ;   et al. | 2010-01-28 |
Novel Derivatives App 20100016330 - Heer; Jag Paul ;   et al. | 2010-01-21 |
Anthranilic acid derivatives and their use as activators of the hm74a receptor App 20070191378 - Campbell; Matthew ;   et al. | 2007-08-16 |
Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase App 20050014938 - Gaster, Laramie Mary ;   et al. | 2005-01-20 |
Thiazolyl substituted triazoles as alk5 inhibitors App 20040266842 - Gaster, Laramie Mary ;   et al. | 2004-12-30 |
Pyridinylimidazoles App 20040220230 - Gaster, Laramie Mary ;   et al. | 2004-11-04 |
Pyridyl-substituted triazoles as tgf inhibitors App 20040152738 - Gaster, Laramie Mary ;   et al. | 2004-08-05 |
Pyridinylimidazoles App 20030166633 - Gaster, Laramie Mary ;   et al. | 2003-09-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.